How high-density lipoprotein protects against the effects of lipid peroxidation

被引:157
作者
Mackness, MI [1 ]
Durrington, PN [1 ]
Mackness, B [1 ]
机构
[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
关键词
D O I
10.1097/00041433-200008000-00007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protective effect of HDL against the development of atherosclerosis appears to be multifaceted involving a number of mechanisms. One of the major mechanisms is, however, the ability of HDL to decrease, directly or indirectly, the lipid peroxidation of LDL, The hydrolysis of lipid peroxides by PON1 makes a major contribution to this effect of HDL. Evidence is accumulating that the PON1 activity of human serum can be modulated by a variety of natural compounds and that these may increase or decrease the protective ability of PON1 and therefore of HDL on which it is exclusively located. Modulations of PON1 that enhance its activity may help to delay the atherosclerotic process. Curr Opin Lipidol 11:383-388. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 64 条
  • [1] Gin → Arg 191 polymorphism of paraoxonase and Parkinson's disease
    Akhmedova, S
    Anisimov, S
    Yakimovsky, A
    Schwartz, E
    [J]. HUMAN HEREDITY, 1999, 49 (03) : 178 - 180
  • [2] ARROL S, 2000, IN PRESS ATHEROSCLER
  • [3] High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
    Assmann, G
    Schulte, H
    vonEckardstein, A
    Huang, YD
    [J]. ATHEROSCLEROSIS, 1996, 124 : S11 - S20
  • [4] Risk of myocardial infarction associated with GIn/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus
    Aubó, C
    Sentí, M
    Marrugat, J
    Tomás, M
    Vila, J
    Sala, J
    Masiá, R
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (01) : 33 - 38
  • [5] Does paraoxonase play a role in susceptibility to cardiovascular disease?
    Aviram, M
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (09): : 381 - 386
  • [6] Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R
    Aviram, M
    Billecke, S
    Sorenson, R
    Bisgaier, C
    Newton, R
    Rosenblat, M
    Erogul, J
    Hsu, C
    Dunlop, C
    La Du, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) : 1617 - 1624
  • [7] Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants
    Aviram, M
    Rosenblat, M
    Billecke, S
    Erogul, J
    Sorenson, R
    Bisgaier, CL
    Newton, RS
    La Du, B
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) : 892 - 904
  • [8] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [9] Serum paraoxonase after myocardial infarction
    Ayub, A
    Mackness, MI
    Arrol, S
    Mackness, B
    Patel, J
    Durrington, PN
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (02) : 330 - 335
  • [10] Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models
    Benoit, P
    Emmanuel, F
    Caillaud, JM
    Bassinet, L
    Castro, G
    Gallix, P
    Fruchart, JC
    Branellec, D
    Denèfle, P
    Duverger, N
    [J]. CIRCULATION, 1999, 99 (01) : 105 - 110